title: A Human-Specific α7-Nicotinic Acetylcholine Receptor Gene in Human Leukocytes: Identification, Regulation and the Consequences of CHRFAM7A Expression.
abstract: The human genome contains a variant form of the α7-nicotinic acetylcholine receptor (α7nAChR) gene that is uniquely human. This CHRFAM7A gene arose during human speciation and recent data suggests that its expression alters ligand tropism of the normally homopentameric human α7-AChR ligand-gated cell surface ion channel that is found on the surface of many different cell types. To understand its possible significance in regulating inflammation in humans, we investigated its expression in normal human leukocytes and leukocyte cell lines, compared CHRFAM7A expression to that of the CHRNA7 gene, mapped its promoter and characterized the effects of stable CHRFAM7A overexpression. We report here that CHRFAM7A is highly expressed in human leukocytes but that the levels of both CHRFAM7A and CHRNA7 mRNAs were independent and varied widely. To this end, mapping of the CHRFAM7A promoter in its 5'-untranslated region (UTR) identified a unique 1-kb sequence that independently regulates CHRFAM7A gene expression. Because overexpression of CHRFAM7A in THP1 cells altered the cell phenotype and modified the expression of genes associated with focal adhesion (for example, FAK, P13K, Akt, rho, GEF, Elk1, CycD), leukocyte transepithelial migration (Nox, ITG, MMPs, PKC) and cancer (kit, kitL, ras, cFos cyclinD1, Frizzled and GPCR), we conclude that CHRFAM7A is biologically active. Most surprisingly however, stable CHRFAM7A overexpression in THP1 cells upregulated CHRNA7, which, in turn, led to increased binding of the specific α7nAChR ligand, bungarotoxin, on the THP1 cell surface. Taken together, these data confirm the close association between CHRFAM7A and CHRNA7 expression, establish a biological consequence to CHRFAM7A expression in human leukocytes and support the possibility that this human-specific gene might contribute to, and/or gauge, a human-specific response to inflammation.
authors: Department of Surgery, University of California San Diego Health Sciences, San Diego, California, United States of America.
authors: Todd W
authors: TW
authors: Costantini
authors: Department of Surgery, University of California San Diego Health Sciences, San Diego, California, United States of America.|Cardiovascular Research Center, Luzhou Medical College, Luzhou, Sichuan, China.
authors: Xitong
authors: X
authors: Dang
authors: Department of Surgery, University of California San Diego Health Sciences, San Diego, California, United States of America.
authors: Maryana V
authors: MV
authors: Yurchyshyna
authors: Department of Surgery, University of California San Diego Health Sciences, San Diego, California, United States of America.
authors: Raul
authors: R
authors: Coimbra
authors: Department of Surgery, University of California San Diego Health Sciences, San Diego, California, United States of America.
authors: Brian P
authors: BP
authors: Eliceiri
authors: Department of Surgery, University of California San Diego Health Sciences, San Diego, California, United States of America.
authors: Andrew
authors: A
authors: Baird
mesh_terms: D017398:Alternative Splicing; D002460:Cell Line; D005786:Gene Expression Regulation; D006801:Humans; D007962:Leukocytes / Q000378:metabolism*; D008954:Models, Biological; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms; D012333:RNA, Messenger / Q000235:genetics; D014158:Transcription, Genetic; D064569:alpha7 Nicotinic Acetylcholine Receptor / Q000235:genetics* / Q000378:metabolism*
chemical_list: D020033:Protein Isoforms; D012333:RNA, Messenger; D064569:alpha7 Nicotinic Acetylcholine Receptor